Michael D. Lesh, SM MD FACC

Founder and CEO, Quench, Inc.
San Francisco Bay Area,United States
Find Michael D. Lesh, SM MD FACC's Email
Find Michael D. Lesh, SM MD FACC's Phone

Who Is Michael D. Lesh, SM MD FACC?

Total Experience57 years
CompanyQuench, Inc.
CountryUnited States

Dr. Michael D. Lesh is a highly accomplished cardiologist, cardiac electrophysiologist, inventor, and serial entrepreneur with extensive experience in academic medicine and the medical device industry. He is recognized for his pioneering work in the treatment of atrial fibrillation and other cardiac arrhythmias. Dr. Lesh served as Professor of Medicine and Chief of Cardiac Electrophysiology at the University of California, San Francisco (UCSF). He has founded multiple successful medical technology companies, including Atrionix (acquired by Johnson & Johnson), Appriva Medical (acquired by Medtronic), and MyPace (now Axon Therapies), where he serves as CEO. His work focuses on developing innovative, less invasive therapies for cardiovascular diseases, significantly impacting patient care worldwide.

How Did Michael D. Lesh, SM MD FACC's Career Path Shape Their Journey?

Michael D. Lesh, SM MD FACC's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Quench, Inc. - Founder and CEO(2023 to Present)
Syntegra - Founder and CEO(2020 to Present)
Elucid - Independent Director(2022 to Present)
Cordance Medical - Executive Chairman(2018 to Present)
University of California, San Francisco - Adjunct Professor of Medicine(2018 to Present)
UCSF Innovation Ventures - Catalyst Translational Accelerator(2017 to Present)
VizaraMed, Inc. - Independent Director(2023 to Present)
KidneyCor - Executive Chairman(2018 to Present)
UCSF Health Hub - Board Of Directors(2018 to 2021)
STENTYS - Independent Director(2008 to 2017)

What Are Michael D. Lesh, SM MD FACC's Key Achievements?

Pioneering Work in Atrial Fibrillation Treatment

Dr. Lesh is globally recognized for his foundational research and development of catheter-based ablation techniques for atrial fibrillation, which have become a cornerstone of modern arrhythmia management.

Successful MedTech Entrepreneur

Founded and led multiple innovative medical device companies, including Atrionix (focused on AF ablation, acquired by J&J), Appriva Medical (left atrial appendage occlusion, acquired by Medtronic), and currently CEO of Axon Therapies (developing a novel therapy for heart failure).

Distinguished Academic Career at UCSF

Served as Professor of Medicine and Chief of the Cardiac Electrophysiology section at the University of California, San Francisco (UCSF), contributing significantly to research, teaching, and clinical excellence.

Prolific Inventor

Holds numerous U.S. and international patents for medical devices and procedures, particularly in the field of cardiac rhythm management and cardiovascular therapies.

Fellow of the American College of Cardiology (FACC)

Recognized by his peers for his significant contributions to cardiovascular medicine and his commitment to the highest standards of patient care and research.

What's Michael D. Lesh, SM MD FACC's Educational Background?

S.B. & S.M., Computer Science & Biomedical Engineering

Massachusetts Institute of Technology - Year 1971

Doctor of Medicine (MD)

University of California, San Francisco - Year 1977

Resident, Internal Medicine

University of California, San Francisco - Year 1981

Fellow, Cardiology and Cardiac Electrophysiology

University of Pennsylvania School of Medicine - Year 1985

Buying Intent Signals for Michael D. Lesh, SM MD FACC

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Quench, Inc.
Total employees1200
HeadquartersKing of Prussia
Founded2008

Quench USA, Inc. offers businesses a wide array of filtered water solutions, including bottleless water coolers, ice machines, sparkling water dispensers, and coffee brewers. They focus on providing sustainable, cost-effective, and convenient hydration and beverage options for workplaces and commercial environments, aiming to eliminate the environmental impact and hassle of traditional bottled water delivery and single-use plastic bottles.

Quench, Inc. Funding Information
Unknown - Total Funding Raised
$115M - Most recent funding amount
4 - Number of funding rounds
1 Nov, 2012 - Latest funding round
Lead Investors:
Culligan International (Acquirer)
BDT Capital Partners (via Culligan)
Advent International (via Culligan)
Warburg Pincus (Historical primary investor pre-acquisition)

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.